TY  - GEN
AU  - Wadler,S
AU  - Gleissner,B
AU  - Hilgenfeld,R U
AU  - Thiel,E
AU  - Haynes,H
AU  - Kaleya,R
AU  - Rozenblit,A
AU  - Kreuser,E D
TI  - Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma
SN  - 0959-8049
PY  - 1996///1009
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Aspartic Acid
KW  - administration & dosage
KW  - Fluorouracil
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Middle Aged
KW  - Phosphonoacetic Acid
KW  - Recombinant Proteins
KW  - Stomach Neoplasms
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/0959-8049(96)00035-4
ER  -